Argent Trust Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89M | Sell |
34,215
-2,785
| -8% | -$151K | 0.06% | 247 |
|
|
2025
Q4 | $1.81M | Sell |
37,000
-796
| -2% | -$37.1K | 0.06% | 249 |
|
|
2025
Q3 | $1.63M | Sell |
37,796
-1,432
| -4% | -$55.9K | 0.06% | 267 |
|
|
2025
Q2 | $1.51M | Buy |
39,228
+4,678
| +14% | +$179K | 0.06% | 270 |
|
|
2025
Q1 | $1.34M | Buy |
34,550
+78
| +0.2% | +$2.86K | 0.05% | 272 |
|
|
2024
Q4 | $1.17M | Buy |
34,472
+2,012
| +6% | +$72.4K | 0.05% | 286 |
|
|
2024
Q3 | $1.33M | Sell |
32,460
-794
| -2% | -$32.5K | 0.05% | 273 |
|
|
2024
Q2 | $1.28M | Buy |
33,254
+765
| +2% | +$32.2K | 0.06% | 269 |
|
|
2024
Q1 | $1.39M | Buy |
32,489
+75
| +0.2% | +$3.09K | 0.06% | 254 |
|
|
2023
Q4 | $1.2M | Sell |
32,414
-374
| -1% | -$13.4K | 0.06% | 254 |
|
|
2023
Q3 | $1.19M | Sell |
32,788
-1,232
| -4% | -$43.7K | 0.07% | 247 |
|
|
2023
Q2 | $1.21M | Sell |
34,020
-1,473
| -4% | -$52.8K | 0.07% | 237 |
|
|
2023
Q1 | $1.26M | Buy |
35,493
+532
| +2% | +$18.6K | 0.08% | 208 |
|
|
2022
Q4 | $1.23M | Sell |
34,961
-2,763
| -7% | -$92K | 0.08% | 209 |
|
|
2022
Q3 | $1.11M | Buy |
37,724
+776
| +2% | +$29.4K | 0.08% | 210 |
|
|
2022
Q2 | $2.01M | Sell |
36,948
-800
| -2% | -$44.2K | 0.14% | 148 |
|
|
2022
Q1 | $2.06M | Buy |
37,748
+4,731
| +14% | +$257K | 0.13% | 153 |
|
|
2021
Q4 | $1.82M | Sell |
33,017
-796
| -2% | -$41.4K | 0.11% | 172 |
|
|
2021
Q3 | $1.61M | Sell |
33,813
-1,104
| -3% | -$55.5K | 0.1% | 174 |
|
|
2021
Q2 | $1.74M | Sell |
34,917
-526
| -1% | -$25.3K | 0.11% | 164 |
|
|
2021
Q1 | $1.58M | Buy |
35,443
+1,701
| +5% | +$77.2K | 0.11% | 172 |
|
|
2020
Q4 | $1.55M | Sell |
33,742
-13,056
| -28% | -$600K | 0.12% | 159 |
|
|
2020
Q3 | $2.2M | Sell |
46,798
-2,692
| -5% | -$135K | 0.19% | 112 |
|
|
2020
Q2 | $2.52M | Sell |
49,490
-1,304
| -3% | -$66.9K | 0.24% | 97 |
|
|
2020
Q1 | $2.41M | Sell |
50,794
-2,774
| -5% | -$148K | 0.27% | 89 |
|
|
2019
Q4 | $3.15M | Buy |
53,568
+1,949
| +4% | +$108K | 0.28% | 89 |
|
|
2019
Q3 | $2.75M | Buy |
51,619
+943
| +2% | +$48.5K | 0.27% | 91 |
|
|
2019
Q2 | $2.54M | Sell |
50,676
-2,056
| -4% | -$103K | 0.26% | 96 |
|
|
2019
Q1 | $2.75M | Buy |
52,732
+6,048
| +13% | +$302K | 0.29% | 86 |
|
|
2018
Q4 | $2.23M | Buy |
46,684
+41,745
| +845% | +$2.06M | 0.26% | 97 |
|
|
2018
Q3 | $248K | Hold |
4,939
| – | – | 0.03% | 379 |
|
|
2018
Q2 | $248K | Buy |
+4,939
| New | +$249K | 0.03% | 378 |
|
Other funds holding GSK
JEST
Argent Trust Co's GSK Position: Q1 2026 in Review
Argent Trust Co reduced its GSK (GSK) stake by 7.5% in Q1 2026, selling an estimated $151K and leaving 34,215 shares worth $1.89M. The position accounts for 0.06% of the portfolio, ranked #247.
Argent Trust Co first reported a position in GSK in Q2 2018 and has held it in 32 quarters since. The position peaked at $3.15M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Argent Trust Co held 34,215 shares of GSK worth $1.89M as of Q1 2026.
- Argent Trust Co sold 2,785 GSK shares in Q1 2026, an estimated $151K.
- GSK made up 0.06% of Argent Trust Co's portfolio in Q1 2026, its #247 holding.
- Argent Trust Co first reported a position in GSK in Q2 2018 and has held it in 32 quarters since.
- Argent Trust Co's GSK position peaked at $3.15M in Q4 2019.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.